← Leaderboards
Suresh Vedantham
Washington University
$19,226,475
Attributed
$21,082,635
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,082,635 · 5
By mechanism
UH3$11,856,799 · 2
U01$7,194,790 · 1
UG3$1,376,983 · 1
U34$654,063 · 1
Top collaborators
- Sunil V Rao2 shared
Most similar at Washington University
Same institution · by research overlap
- Colin Pieter Derdeyn$10,282,174
- Jennifer P Ruger$3,336,348
- Yo-El S Ju$21,872,970
- Mohamed A. Zayed$7,854,663
- Dana R Abendschein$2,878,423
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteCathetersDisabilityCostQuality Of LifeImpairmentClinical PracticeThrombolysisThrombusVeinsDeep Vein ThrombosisVenousLeg UlcerMedicalVenous ThrombosisHealth Related Quality Of LifeCost EffectivenessExcisionMissionPreventPostphlebitic SyndromeRandomized Controlled TrialsOpen LabelAnatomy
Grant awards (15)
1/2 Pulmonary Embolism: Thrombus Removal with Catheter-Directed Therapy (PE-TRACT Trial)$1,859,087
UH3 · FY2025 · HL
1/2 Pulmonary Embolism: Thrombus Removal with Catheter-Directed Therapy (PE-TRACT Trial)$1,853,234
UH3 · FY2024 · HL
1/2 CATHETER-DIRECTED THERAPY FOR CHRONIC DVT (C-TRACT TRIAL)$1,213,638
UH3 · FY2023 · HL · contact PI
1/2 CATHETER-DIRECTED THERAPY FOR CHRONIC DVT (C-TRACT TRIAL)$1,522,853
UH3 · FY2022 · HL · contact PI
1/2 CATHETER-DIRECTED THERAPY FOR CHRONIC DVT (C-TRACT TRIAL)$1,688,353
UH3 · FY2021 · HL · contact PI
1/2 CATHETER-DIRECTED THERAPY FOR CHRONIC DVT (C-TRACT TRIAL)$1,876,466
UH3 · FY2019 · HL · contact PI
1/2 CATHETER-DIRECTED THERAPY FOR CHRONIC DVT (C-TRACT TRIAL)$1,843,168
UH3 · FY2018 · HL · contact PI
1/2 CATHETER-DIRECTED THERAPY FOR CHRONIC DVT (C-TRACT TRIAL)$1,376,983
UG3 · FY2017 · HL · contact PI
CHRONIC VENOUS THROMBOSIS: RELIEF WITH ADJUNCTIVE CATHETER-BASED THERAPY (C-TRACT$311,278
U34 · FY2015 · HL · contact PI
CHRONIC VENOUS THROMBOSIS: RELIEF WITH ADJUNCTIVE CATHETER-BASED THERAPY (C-TRACT$342,785
U34 · FY2014 · HL · contact PI
PHARMACOMECHANICAL CATHETER-DIRECTED THROMBOLYSIS FOR ACUTE DVT - ATTRACT TRIAL$1,074,400
U01 · FY2013 · HL · contact PI
PHARMACOMECHANICAL CATHETER-DIRECTED THROMBOLYSIS FOR ACUTE DVT - ATTRACT TRIAL$1,373,888
U01 · FY2012 · HL · contact PI
PHARMACOMECHANICAL CATHETER-DIRECTED THROMBOLYSIS FOR ACUTE DVT - ATTRACT TRIAL$1,623,490
U01 · FY2010 · HL · contact PI
PHARMACOMECHANICAL CATHETER-DIRECTED THROMBOLYSIS FOR ACUTE DVT - ATTRACT TRIAL$1,630,724
U01 · FY2009 · HL · contact PI
PHARMACOMECHANICAL CATHETER-DIRECTED THROMBOLYSIS FOR ACUTE DVT - ATTRACT TRIAL$1,492,288
U01 · FY2008 · HL · contact PI